Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciad525 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Daniel J Minter und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Bacteremia, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
- Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
ORCID-Profile: Daniel J Minter, Ayesha Appa
Zitieren
APA
Minter, D. J., Appa, A., Chambers, H. F., & Doernberg, S. B. (2023). Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad525
Vancouver
Minter DJ, Appa A, Chambers HF, Doernberg SB. Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad525
BibTeX
@article{Minter2023,
author = {Minter, Daniel J and Appa, Ayesha and Chambers, Henry F and Doernberg, Sarah B},
title = {Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciad525}
}
EUVIMED